Agoracom Blog Home

Archive for the ‘Featured’ Category

Loop Insights $MTRX.ca Signs Agreement With #NCAA DIV. 1 SCHOOL – University Of Houston Athletics To Implement Contactless Platform For Tracing And Cashless Commerce $QUIS.ca $MCLD.ca $NXO.ca

Posted by AGORACOM-JC at 7:09 AM on Wednesday, September 16th, 2020
Loop Insights – Medium
  • Announces the signing of an agreement with the University of Houston Athletics to implement Loop’s contactless, artificial intelligence marketing solutions
  • Will provide personalized promotions and targeted engagement, as well as, Loop’s leading contact tracing solutions for the purposes of supporting resumption plans that provide a safe environment for fans and guests attending Houston football games at TDECU Stadium
  • Loop’s e-commerce solutions will be integrated within the platform to provide fans with an ability to purchase event tickets, concessions, merchandise products, and parking services without having to use physical cash

VANCOUVER, BC, Sept. 16, 2020 – Loop Insights Inc. (MTRX: TSXV) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, is pleased to announce the signing of an agreement with the University of Houston Athletics (“UH”) to implement Loop’s contactless, artificial intelligence marketing solutions to provide personalized promotions and targeted engagement, as well as, Loop’s leading contact tracing solutions for the purposes of supporting resumption plans that provide a safe environment for fans and guests attending Houston football games at TDECU Stadium.

The University of Houston is a public research university in Houston, Texas, and the main institution of the University of Houston System. Founded in 1927, UH is the third-largest university in Texas, with over 47,000 students.

LOOP SOLUTION TO PROVIDE HOUSTON ATHLETICS WITH ABILITY TO ACHIEVE CASHLESS AND CONTACTLESS GOALS

Given the health risks related to COVID-19 and the uncertainty about the duration of its impact on society, UH Athletics will be working with Loop in the development and implementation of a contactless and cashless solution for fans and guests attending events at TDECU Stadium. Loop’s services will help Houston Athletics deliver on this goal by first implementing its contact tracing solution, which will provide Houston football fans and guests safe and secure access when attending events. 

Secondly, Loop’s e-commerce solutions will be integrated within the platform to provide fans with an ability to purchase event tickets, concessions, merchandise products, and parking services without having to use physical cash. 

Finally, with users now using the platform to conduct their purchases and access events, Loop’s artificial intelligence marketing services will provide unmatched personalized promotions and engagement opportunities, creating a more interactive fan experience at Houston athletic events. Loop’s services and technologies will offer a more robust game day experience for all Houston football fans.

Loop Insights CEO Rob Anson stated, “Our first priority is reopening and keeping campus doors open through our proven and scalable contact tracing platform. Secondly, we want to help UH maintain and increase its revenues. We expect to generate meaningful revenue from monthly fees associated to active users on the Loop platform as well through participation in a revenue share. With our integrated product stack, UH and all of the other 356 NCAA Div.1 colleges can gain immediate access to all of Loop’s products and services and benefit from increased profitability through streamlined operational efficiencies. We intend to deliver a future proof campus experience, so the next wave of Covid-19 does not close their doors for good. Loop is the complete solution.”  

University of Houstons Deputy Athletic Director David Tagliarino stated, “A main goal for us is to administer enhanced safety protocols and best practices, measures that instill confidence among our fans and guests during these challenging times due to Covid-19. Loop’s solution is appealing because it also provides fully automated and personalized fan experiences with large-scale user adoption and enhanced fan engagement opportunities. In addition to improving the way we interact with fans inside and outside the stadium, Loop’s contact tracing will greatly assist our efforts in returning fans to our venues in a safe and prudent manner.”

This Press Release Is Available On The Loop Insights Verified Forum On AGORACOM For Shareholder Discussion and Q&A https://agoracom.com/ir/LoopInsights/forums/discussion

About Houston Athletics

University of Houston Athletics sponsors 17 intercollegiate sports for nearly 400 student-athletes. The department’s mission is to develop its student-athletes into champions for life and focuses daily on the success and welfare of its student-athletes. A member of the American Athletic Conference, Houston has led its league in conference championships in each of the last five seasons. For more information on UH Athletics, visit UHCougars.com.

About Loop Insights

Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.

Forward-Looking Statements/Information: 

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives. 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

SOURCE LOOP Insights Inc.

ECHL’s Allen Americans Select ImagineAR $IP.ca $IPNFF For Fan Engagement & Sponsorship Programs $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:01 AM on Wednesday, September 16th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Selected by the Allen Americans of the ECHL (Premier “AA” Hockey League)
  • The Allen Americans previously used ImagineAR to support local restaurant partners whose operations have been affected by the Coronavirus pandemic with the initiative, “Biscuit’s Curbside Pick Up”.
  • Neal Bendesky, VP Sports & Live Events of ImagineAR, said “The Allen Americans are leaders in the ECHL in leveraging ImagineAR to support their community partners. We are excited to extend their current AR partner program that activated their mascot Biscuit. Their new digital strategy will provide a more immersive experience for their fans that will create social media engagement.”

VANCOUVER, BC and ERIE, PA, Sept. 16, 2020 –ImagineAR Inc. (CSE: IP) (OTC: IPNFF), the company providing augmented reality (AR) fan engagement experiences for sports teams, announced they have been selected by the Allen Americans of the ECHL (Premier “AA” Hockey League).  The Allen Americans previously used ImagineAR to support local restaurant partners whose operations have been affected by the Coronavirus pandemic with the initiative, “Biscuit’s Curbside Pick Up”.

“The Allen Americans are excited to be expanding our ability to provide an iconic gameday atmosphere through the addition of this cutting-edge partnership with ImagineAR,” shares Allen Americans Team President and Alternate Governor Mike Waddell, “The immersive augmented reality engagements will deliver a new dimension of fan experiences with our Athletes, Coaches, Ice Angels and of course, the coolest dog on ice, Biscuit the Bulldog. The creativity is open ended so this ImagineAR technology will be continually evolving.”

Neal Bendesky, VP Sports & Live Events of ImagineAR, said “The Allen Americans are leaders in the ECHL in leveraging ImagineAR to support their community partners.  We are excited to extend their current AR partner program that activated their mascot Biscuit.  Their new digital strategy will provide a more immersive experience for their fans that will create social media engagement.”

About Allen Americans
The Allen Americans are the ECHL affiliate of the National Hockey League‘s Minnesota Wild and the American Hockey League‘s Iowa Wild. Championship Hockey is the backbone of the American’s franchise since being founded prior to the 2009-10 season, with the Red, White and Blue having captured two ECHL Kelly Cup Championships (2014-15 & 2015-16) and two Central Hockey League President’s Cups (2012-13 & 2013-14). Americans’ home games are played at the Allen Event Center, which is located in The Village at Allen. Owned by nationally respected “Serial Entrepreneur” Jack D. Gulati, the Club begins its 12th season of professional hockey in December 2020.  Season tickets are on sale now at AllenAmericans.com/tickets or by calling 972-912-1000.

About ImagineAR
Imagine AR Inc. (CSE: IP) (OTC: IPNFF) has developed ImagineAR.com; an “AR-as-a-Service” platform for desktops that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds using ImagineARTM. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage with videos, information, advertisements, coupons, 3D holograms and any interactive content, all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The ImagineAR.com mobile app is available in the IOS and Android mobile app stores.

For more information or to explore working with ImagineAR, please visit www.imaginear.com.

All trademarks of the property of respective owners.
ON BEHALF OF THE BOARD
Alen Paul Silverrstieen
President & CEO
(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if Imagine AR  Inc. (CSE: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR’s management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

CEO SPOTLIGHT: Iris Bincovich, CEO of Innocan Pharma $INNO.ca $WEED.ca $CL.ca $HEXO.ca $RWB.ca

Posted by AGORACOM-JC at 4:52 PM on Tuesday, September 15th, 2020
Innocan-Blog

Hub On AGORACOM / Corporate Profile

Innocan Phrama $INNO.ca Completes Successful Cosmetic Clinical Studies Demonstrating the Efficacy of Its SHIR(TM) CBD Premium Facial Serum on Skin Hydration $GWPH $CRDL.ca $PCLO.ca

Posted by AGORACOM-JC at 4:07 PM on Tuesday, September 15th, 2020
Innocan-Blog
  • Completed a cosmetic clinical study examining the impact of its SHIR ™ Premium CBD Facial Serum containing 300 mg of cannabidiol on skin hydration
  • Results demonstrated that there were significant hydration increases for each period
  • The Serum was well tolerated with no uncomfortable symptoms or feelings reported by the subjects of the study

Herzliya, Israel and Calgary, Alberta–(September 15, 2020) –   Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce today, that it has completed a cosmetic clinical study examining the impact of its SHIR ™ Premium CBD Facial Serum containing 300 mg of cannabidiol (“CBD“) (the “Serum”) on skin hydration.

The study was conducted by an independent research laboratory: INOVAPOTEK, Pharmaceutical Research and Development in Portugal”. The study aimed to assess the hydrating efficacy of the Serum in vivo, by measuring the skin capacitance for a period of 2, 4, 8 and 24 hours after the CBD Serum application on the skin. The results demonstrated that there were significant hydration increases for each period. The Serum was well tolerated with no uncomfortable symptoms or feelings reported by the subjects of the study.

In addition, the research laboratory completed a clinical controlled study for the evaluation of the acute cutaneous irritation potential of cosmetic products. All of the SHIR™ Derma Cosmetic products tested to date have demonstrated to be non-irritating under the test conditions.

“The results of these studies have demonstrated the efficacy of the SHIR ™ Premium CBD Facial Serum product. Hydrating the skin is one of the most crucial measures to keep the skin healthy, young and also to eliminate wrinkles. The amazing results of the new clinical studies are in addition to Innocan’s research and development efforts to bring to market, a trustworthy product that will set a new industry standard, stated Iris Bincovich, Chief Executive Officer of Innocan.”

Figure 1

To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/6922/63880_98aa5e38b4389924_003full.jpg

About Innocan

The Company, through its wholly owned subsidiary, Innocan Israel, is a pharmaceutical tech company that focuses on the development of several drug delivery platforms containing CBD. Innocan Israel and Ramot at Tel Aviv University, are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the Covid-19 Corona Virus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem, to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholtz Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan Israel have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

St-Georges Eco-Mining $SX.ca $SXOOF: First Hole Completed at Thor Gold Project $NNX.ca $OM.ca $ICM.ca

Posted by AGORACOM-JC at 9:10 AM on Tuesday, September 15th, 2020
  • Completed its first reverse circulation drill hole at the Thor project in the vicinity of Reykjavik in Iceland
  • The hole was positioned to test a previous surface sample that assayed 37.4 g/t gold and 69.3 g/t silver
  • The hole was successfully ended at 124 meters

Reykjavik – September 15, 2020 – St-Georges Eco-Mining Corp. (CSE:SX) (CNSX:SX.CN) (OTC:SXOOF) (FSE:85G1) is pleased to disclose that it has completed its first reverse circulation drill hole at the Thor project in the vicinity of Reykjavik in Iceland. The hole was positioned to test a previous surface sample that assayed 37.4 g/t gold and 69.3 g/t silver. The hole was successfully ended at 124 meters.

The exploration team lead by Pr Helen Salmon and supported by Herb Duerr and lead field geologist Gary McLearn, had identified earlier in August a new target zone outside the historically explored area following the grab sample results from sample 008 that yielded 69.3 g/t silver, 0.216% Copper & 37.4 g/t Gold. (See Company’s Press Release from August 21, 2020).

Because of high grades in past mining and the presence of visible gold in past work, a decision to sample the hole on 30 cm intervals was made by management. Our contract geologist may have observed visible grains of gold and possible accessory silver minerals near the bottom of the hole. As such, management has decided to do a standard 50 assay ton fire assay with atomic absorption finish for both gold and silver. Any samples assaying over 0.8 g/t gold will be automatically reassayed. If the samples are inconsistent, the lab will be instructed to do metal screening for particulate gold on reject material.

The current surface exploration campaign conducted one drill hole via reverse circulation using a standard hammer drill bit of 5.5 inches (~14 cm) in size. The drilling was conducted under the constant supervision of the Company’s field geologist, and all the material of every 30cm of depth was collected in plastic buckets sealed, identified with a code, and carried to St-Georges’ secure warehousing facilities in Reykjavik. From there, the geologists will prepare a representative sample for every bucket. Based on the visual analysis conducted while logging the material so far, the Company expects to send over 400 samples to be assayed to ALS Global Laboratories (ISO/IEC 17025 accredited) in Loughrea, Ireland. The Company intends to request a rush treatment for the assay of these samples.

The hole completed went from surface to a depth of 124 meters on an azimuth of 110 degrees. The drill rig cased the hole to 2 meters depth encountering approximately 1.5 meters of overburden at the surface. The mineralization encountered is compatible with the type often favorable for gold on the Thor project consisting of quartz veining adjacent to basalt with apparent abundant pyrite and accessory sulphides. Visible gold and silver may have been identified in the field by the Company’s field geologist. These sections are still being logged and sampled and prepared to be sent to the laboratory. See Figures 1, 2 & 3.


Click Image To View Full Size

Figure 1. Mineralization floating on top of drilling mud


Click Image To View Full Size

Figure 2. Mineralization from quartz veining

Figure 3. Mineralization close up from Fig. 2

St-Georges’ President & CEO, Vilhjalmur Thor Vilhjalmsson, commented: “(…) We are encouraged by the current pace of the exploration work on the Thor Gold Project. The team has worked with the constraints of the COVID-19 quarantine and additional precautions imposed by the new government regulations, and still ended-up delivering within the aggressive target dates we had put forward (…) We are particularly pleased with the field team led by Gary. We have given the team much leeway and trusted their professional expertise. Gary took a bold decision in choosing an underexplored location for the only deeper drill hole we were authorized for to date under our agreement with Melmis. For what we know so far, it was worth the risk (…) we expect to close the transaction with Melmis this month, and we will keep the drilling contractor busy for the foreseeable future on the Thor Gold Project (…)”.

About Thor Gold

The Thormodsdalur Gold Project is located about 20km east of the city center of Reykjavik and south-east of the Lake Hafravatn. The project was discovered in 1908. The property produced a gold concentrate from 1911 to 1925, which shipped to Germany for processing. Over 300 meters of tunnels explored and mined one or more quartz veins and wall rock below open cuts at the surface.

Studies between 1996 and 2013 identified the project mineralization as a low sulfidation system hosted by basic to intermediate flows of Pliocene to Miocene age. The host contains banded chalcedony and ginguro within a fault zone up to 5 meters in width. To date, the identified gold trend has a known strike length of 700 meters determined by drill intercepts. Petrographic analysis of the vein material identified gold occurring in its free form and as part of an assemblage with pyrite and chalcopyrite. Petrographic and XRD studies show an evolution of the vein system from the zeolite assemblage to quartz-adularia and lastly, to minor calcite.

Thirty-two holes have been drilled within the license area, for a total of 2439 meters. Gold values vary from less than 0.5 g/t to a maximum of 415 g/t. (These values were obtained from selected random intervals and cannot be construed to be representative of any particular thickness or overall length.) Historically, the best intercepts from the diamond drilling are 33.5m of 8.0 g/t Au (true thickness) and 5.2m of 35.4 g/t Au (true thickness).

Gary McLearn, A professional geoscientist (Ontario APGO #2900) and an Independent Qualified Person as defined by National Instrument 43-101, has prepared, supervised the preparation or approved the scientific and technical disclosure in the news release.

ON BEHALF OF THE BOARD OF DIRECTORS

“Vilhjalmur Thor Vilhjalmsson”

Vilhjalmur Thor Vilhjalmsson

President and CEO

About St-Georges

St-Georges is developing new technologies to solve some of the most common environmental problems in the mining industry.

The Company controls directly or indirectly, through rights of first refusal, all of the active mineral tenures in Iceland. It also explores for nickel on the Julie Nickel Project & for industrial minerals on Quebec’s North Shore and for lithium and rare metals in Northern Quebec and in the Abitibi region. Headquartered in Montreal, St-Georges’ stock is listed on the CSE under the symbol SX, on the US OTC under the Symbol SXOOF and on the Frankfurt Stock Exchange under the symbol 85G1

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Red Light Holland $TRIP.ca Announces iMicrodose Launch Party on September 25th, 2020 and Engages Leading European Experiential Creative Agency to Host the Premiere Event in Amsterdam $SHRM.ca $RVV.ca

Posted by AGORACOM-JC at 9:05 AM on Tuesday, September 15th, 2020
Red-Light-Holland-Square
  • Engaged Guest Agency, a leading European experiential creative agency, to host the launch event of iMicrodose Microdosing Packs, in the Netherlands.
  • Guest Agency has sought the assistance of their trusted partner, Maison PR for PR and Influencer support
  • The iMicrodose Launch Event will be held Friday, September 25th, 2020, in Amsterdam at the A’DAM the Loft from 6-9 p.m (CEST) for press, artists, thought-leaders, successful entrepreneurs, local celebrities, and social media influencers

Toronto, Ontario–(September 15, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), an Ontario-based corporation positioning itself to engage in the production, growth and sale of its brand of magic truffles to the legal, recreational market within the Netherlands, is pleased to announce it has engaged Guest Agency (“Guest Agency“), a leading European experiential creative agency, to host the launch event of iMicrodose (the “iMicrodose Launch Event“), Microdosing Packs, in the Netherlands. Guest Agency has sought the assistance of their trusted partner, Maison PR (“Maison PR“) for PR and Influencer support.

Guest Agency, founded in 2007, has worked with numerous high caliber clients such as Diageo, Burberry, BMW, Moët & Chandon, Ketel One & Cartier. Their expertise lies in bringing to life immersive, creative experiences and creating brand fans for high regarded and world famous companies.

“We are excited to make a premium splash with our iMicrodose packs to the Netherlands market. We carefully chose Guest Agency housed in Amsterdam, due to their incredible experience with some of the most influential and important brands this world has fallen in love with! We expect the same when people discover iMicrodose, powered by Red Light Holland,” said Todd Shapiro, Chief Executive Officer and Director of the Company. “I’m also pleased to work with Maison PR, to have an opportunity to speak to the press in the Netherlands, as I’m extremely comfortable with the media where we can proudly share information and educate the masses about our iMicrodose product and the Company’s overall vision.”

The iMicrodose Launch Event will be held Friday, September 25th, 2020, in Amsterdam at the A’DAM the Loft from 6-9 p.m (CEST) for press, artists, thought-leaders, successful entrepreneurs, local celebrities, and social media influencers. The event will feature a global live stream presentation by CEO Todd Shapiro, as well as President Hans Derix and will feature local live artists and DJs. The link to the live stream will be available on the company’s website www.redlighttruffles.com



Pictured: A’DAM The Loft

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/63859_325daf60e426d875_001full.jpg



Pictured: A’DAM the Loft

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/2017/63859_325daf60e426d875_002full.jpg

Red Light Holland also announces the resignation of Lowell Kamin as member of the board of directors (the “Board“) of the Company.

The remaining members of the Board and the Company thank Mr. Kamin for his contributions and wish him success with his future endeavors.

About Guest Agency.

Guest Agency is an independent, creative agency focused on telling brand stories and creating word of mouth for various brands that want to create lasting connections with their audience and customers.

Since 2007, Guest Agency has been working for premium, international conglomerates and brands, but also loves to work with local heroes and disruptive players aiming to be (inter)national champions.

Guest Agency is not just another agency, but a hybrid of creativity-driven and execution-strong professionals. With a passionate team of marketeers, creatives, designers and project and event specialists, they create and deliver memorable concepts and campaigns with passion and conviction.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Forward-Looking Statements

Neither the Canadian Securities Exchange (the “CSE”) nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control.

Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward- looking statements contained herein include, but are not limited to, information the timing and other aspects of the iMicrodose Launch Event, including anticipated guests. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward- looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. In particular, there is no guarantee that iMicrodose Launch Event will occur on September 25, 2020, or at all. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Not for distribution to United States newswire services or for dissemination in the United States.

Tartisan Nickel Corp. $TN.ca Expands Kenbridge Nickel Project Land Position and Finds Additional Nickel Targets $NICO.ca $RNX.ca $TSLA $NOB.ca $SHL.ca $CNC.ca

Posted by AGORACOM-JC at 8:27 AM on Tuesday, September 15th, 2020
Tc logo in black
  • Announced that Tartisan has staked an additional ten single-cell mining claims contiguous to the Kenbridge Nickel Deposit patented and unpatented mining claim group, as well as an additional ten single-cell mining claims in a new area some 2.14 km to the northwest
  • The newly acquired claims bring the total claim count to 43 single-cell mining claims adjoining the Kenbridge patented mining claim group

TORONTO, ON / September 15, 2020 / Tartisan Nickel Corp. (CSE:TN)(OTC PINK:TTSRF)(FSE:A2D) (“Tartisan”, or the “Company”) is pleased to announce that Tartisan has staked an additional ten single-cell mining claims contiguous to the Kenbridge Nickel Deposit patented and unpatented mining claim group, as well as an additional ten single-cell mining claims in a new area some 2.14 km to the northwest. The newly acquired claims bring the total claim count to 43 single-cell mining claims adjoining the Kenbridge patented mining claim group. Each single-cell mining claim covers an area of approximately 20.92 ha. for a total area of 899.56 ha. The Kenbridge Nickel Project has now a combined total of 2,287.41 ha. of patented and unpatented mining claims.

The new lands were staked to cover multi-faceted anomalies that were discovered from analysis of spectral data and synthetic aperture data from the Aster Funds Ltd surveys carried out over the Kenbridge Nickel Property and environs.

The Aster Funds Ltd spectral analysis survey generated sixteen different elements, six of which are directly related to the mineral suite at the Kenbridge Nickel Deposit. Five areas with six out of six indicator elements as well as a favourable structural setting were determined, four of which were inside the patented ground and previously staked single-cell mining claims. One such six out of six anomaly was discovered just off the property to the south, also in the structural corridor in which the Kenbridge Nickel Deposit is situated. This newly discovered area was covered by the new claim staking.

In addition, the spectral analysis and synthetic aperture radar surveys outlined other anomalies, further afield. One such area is to the northwest, where a six/six anomaly and large five/six margin may highlight a parallel structure. This anomaly sits on top of a large magnetic anomaly in Ontario Geological Survey data. As well, a five/six anomaly in a large four/six margin was seen on the eastern side of the existing Kenbridge Property, and may represent another mineralized corridor, in as much as two of the minerals were talc and pyrrhotite, which represent mineralization and the host tectonic structure of the Kenbridge Nickel Deposit.

CEO Mr. Mark Appleby said, “The Kenbridge Nickel Deposit sits in a mineralized zone that has a strike length of approximately 250 m, as indicated by drill data. The mineralization has been investigated in detail on two underground levels and with drilling to a depth of 823 m. It makes sense that there may be other similar tectonic structures to the Kenbridge Deposit and the new staking covers two of these potential areas. The Company will follow up on these anomalies on the ground as well as the very prospective targets the surveys found inside the Kenbridge Property boundaries”.

Tartisan Nickel Corp. plans surface exploration and a definition plan for the Kenbridge Project for the autumn of 2020 and winter of 2021.

About Tartisan Nickel Corp.

Tartisan Nickel Corp. is a Canadian based mineral exploration and development company which owns; the Kenbridge Nickel Project in northwestern Ontario, the Sill Lake Silver Property in Sault St. Marie, Ontario as well as the Don Pancho Manganese-Zinc-Lead-Silver Project in Peru. The Company has an equity stake in; Eloro Resources Limited, Class 1 Nickel & Technologies Limited and Peruvian Metals Corp.

Tartisan Nickel Corp. common shares are listed on the Canadian Securities Exchange (CSE:TN; US-OTC:TTSRF; FSE:A2D). Currently, there are 101,603,550 shares outstanding (103,303,550 fully diluted).

For further information, please contact Mr. Mark Appleby, President & CEO and a Director of Tartisan Nickel Corp. at 416-804-0280 ([email protected]). Additional information about Tartisan Nickel Corp. can be found at the Company’s website at www.tartisannickel.com or on SEDAR at www.sedar.com.

Jim Steel MBA P.Geo. is the Qualified Person under NI 43-101 and has read and approved the technical content of this News Release.

This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.

The Canadian Securities Exchange (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release.

SOURCE: Tartisan Nickel Corp.

VIDEO – Kontrol Energy $KNR $KNR.ca $KNR.c $KNRLF Confirms Real-Time Detection Of COVID-19 In The Air – Races Towards Global Commercialization $SNE $MSFT $HON $GOOGL $QCOM $SONA.ca

Posted by AGORACOM-JC at 9:48 AM on Monday, September 14th, 2020
kontrol-logo

Kontrol Energy is the Google NEST of smart building technology, with the Blue Chip client base to prove it.  So when they announced the Receipt Of Positive Lab Results for Live COVID-19 Testing, you need to take them seriously … and the market has with a 63% gain Friday to smash their previous all-time high and close at $4.88

The implications of this announcement appear to be enormous for government buildings, schools and other locations that need to find a way to start bringing people back.  In fact, it isn’t an overstatement to say Kontrol Energy’s BioCloud Analyzer could have a major impact on the global economy, with CEO Paul Ghezzi stating in this interview that calls have already started coming in from all over the world.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

Avicanna’s $AVCN.ca subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical #cannabinoid products with medical prescriptions in Colombia $WEED.ca $TLRY $HARV.ca

Posted by AGORACOM-JC at 7:52 AM on Monday, September 14th, 2020
http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • Authorized cannabinoid products will be available to the medical community and patients in early Q4 2020 including Avicanna’s advanced oral, sublingual, and topical formulations branded and sold as RHO Phyto™ in Canada and other markets.
  • This is the first ever compound pharmacy in Colombia authorized to specialize only in the production of cannabinoid formulations and the first authorized to offer topicals.
  • This is the final step in Avicanna’s fully integrated seed to patient business model in Colombia, which includes cultivation, extraction and manufacturing of pharmaceutical products for the emerging medical market with the 50 million people.

TORONTO, Sept. 14, 2020 – Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that through its wholly owned subsidiary Avicanna LATAM S.A.S. (“Avicanna LATAM“), the Company’s pharmacy in Bogota has been certified with Good Preparation Practices (“GPP“) and authorized by the National Institute for Drug and Food Surveillance (“INVIMA“) for the sale of compounded pharmaceutical products to service medical prescriptions of individual patients in Colombia.

“We are thrilled to be able to offer our pharmaceutical preparations to the Colombian medical and patient communities. While the medical cannabis market in Colombia is still in its infancy, we are committed to educating both physicians and the medical community of the benefits and potential risks of cannabinoid-based medicine for their patients. We are leveraging years of learning and extensive research and development allowing us to provide the Colombian population with standardized and advanced medical solutions.” Aras Azadian CEO, Avicanna Inc.

The GPP authorization permits Avicanna LATAM to manufacture its line of advanced cannabinoid formulations including oral, sublingual, and topical preparations to service individual prescriptions issued by qualified medical professionals such as doctors, hospitals, and third-party independent clinics. The unique cannabinoid formulations are branded as RHO Phyto™ in mature cannabis markets, such as Canada, and are poised to set the standard in Latin America by offering products with years of extensive research and development manufactured with world-class quality standards. All the formulations have been optimized for consistent delivery and increased absorption and are designed to maintain the stability of the cannabinoids over the course of treatment. 

The cannabinoids used in the preparation of these final products are locally-sourced from Avicanna’s majority owned subsidiaries Santa Marta Golden Hemp S.A.S. (“SMGH”) and Sativa Nativa S.A.S. (“SN“) allowing for full control and adherence to the highest quality standards along the entire value chain from seed to finished product. The commercialization strategy for the launch of these medical cannabis products includes education and training of health care professionals and partnerships with third-party hospitals and clinics which have been cultivated over the past few years.

Lucas Nosiglia, President of Avicanna LATAM commented “We are proud to be one of the first companies to offer the Colombian market with these unique product formulations that may address a variety of medical conditions and treat patients across in Colombia. Furthermore, we are providing Colombians with the combination of Avicanna’s advanced formulations and our own organic and sustainably cultivated cannabis from the foothills of the Sierra Nevada in Santa Marta.”

About Avicanna

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.

Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:

  • Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
  • RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.

With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.

Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.

Stay Connected

For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].

Cautionary Note Regarding Forward-Looking Information and Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the Company to provide the Colombian population with standardized and advanced medical solutions, the ability of Avicanna LATAM to manufacture its line of advanced cannabinoid formulations to service individual prescriptions issued by qualified medical professionals, the Company’s ability to set the standard in Latin America by offering products with years of extensive research and development manufactured with world-class quality standards, the ability of the unique formulations to  maintain the stability of the cannabinoids over the course of treatment, the ability of the Company to source the cannabinoids for the manufacture of the medical cannabis products from SMGH and SN, the ability of the product formulations to address specific medical conditions, and the ability of SMGH and SN to continue to cultivate organic and sustainable cannabis. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.

The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

ImagineAR $IP.ca $IPNFF Announces The Appointment Of Chris Dill, Industry Leading Sports Technologist, For Augmented Reality Sports Fan Engagement $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 7:21 AM on Monday, September 14th, 2020
http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg
  • Announced that Chris Dill has joined the Company as an Advisor to the CEO for the purposes of taking ImagineAR platform solutions to professional sports teams and industry leading vendors to enhance fan engagement and generate new revenue streams
  • Mr. Dill, former Portland Trailblazer CIO for over a decade, and is the head of business development for Venuetize a leading sports and venue mobile platform with major clients including the Texas Rangers, LAFC, TD Garden and the Miami Dolphins

VANCOUVER, BC and ERIE, Pa., Sept. 14, 2020  –ImagineAR(CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports organizations, venues and brands to create their own mobile phone AR campaigns is pleased to announce that Chris Dill has joined the Company as an Advisor to the CEO for the purposes of taking ImagineAR platform solutions to professional sports teams and industry leading vendors to enhance fan engagement and generate new revenue streams.

Mr. Dill, former Portland Trailblazer CIO for over a decade, and is the head of business development for Venuetize a leading sports and venue mobile platform with major clients including the Texas Rangers, LAFC, TD Garden and the Miami Dolphins.

CHRIS DILL PROFESSIONAL BACKGROUND

Chris Dill stated, “I am extremely excited to be joining the advisory board for ImagineAR. In my 30 years working in sports and entertainment technology, I have never seen a solution that provides such a high level of interaction and engagement. The potential for matching this technology with sponsorship activations makes it very easy to demonstrate ROI. That’s why I am so thrilled to be a part of the team bringing this game-changing technology to not only sports and entertainment, but a huge variety of other verticals.”

“I met Chris at the 2019 ALSD Conference in Chicago and he moderated our sports technology session. His knowledge of the intersection of sports and technology was impressive and he is highly respected in the North American sports industry”, said Alen Paul Silverrstieen, CEO of ImagineAR.

Chris Dill is bringing 30+ years of experience across sports and technology to ImagineAR as an Advisor to the CEO. For the last 6 years, Chris was head of business development for Venuetize.  Previously Chris spent 22 years at the Portland Trailblazers, the last 12 as CIO, a role in which he spearheaded the team’s technology strategy and execution. From digital signage to mobility to CRM to VoIP, Chris’ vision and management established the Blazers’ reputation across the sports industry as innovative leaders. Never one to innovate “for technology’s sake”, Chris was repeatedly able to demonstrate the true business impact from any of his technology investments, thereby magnifying the impact of his accomplishments. After a successful reign at the Blazers that spanned more than two decades, Chris joined the Sports & Entertainment Alliance in Technology (“SEAT”) as VP of Business Development. After SEAT, Chris has used his industry knowledge and expertise to consult for a wide range of sports technology companies, including Skidata AG (fan loyalty and access control), Signal360 (proximity marketing and beacon technology platform), and Watson Creative (branding, creative services, and responsive website design).

This press release is available on the Company’s AGORACOM Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

About ImagineAR

ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies.

All trademarks of the property of respective owners.

ON BEHALF OF THE BOARD

Alen Paul Silverrstieen
President & CEO

(818) 850-2490
https://twitter.com/IPtechAR
https://www.facebook.com/imaginationparktechnologies
https://www.instagram.com/iptechar
https://www.linkedin.com/company/imagination-park-technologies-inc

We encourage you to do your own due diligence and ask your broker if ImagineAR  Inc. (cse: IP) is suitable for your particular investment portfolio*.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR Inc. management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.